Selective Serotonin Reuptake Inhibitors Sales

Demand For Serotonin-Norepinephrine Reuptake Inhibitors (Snris), Is Set To Increase At A CAGR Of 2% Across The Assessment Period Of 2021 To 2031

2022-01-14 // 0 Comments

The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report [read full press release…]

Home | Submit Press Release | Nationwide / EPR Network | Free Press Release Distribution | Real Time Press Release Distribution | Travel PR News | EuropaWire
© 2004-2024 Express-Press-Release.Net. Owned by EPR Network LLC. All Rights Reserved. All trade marks and names are owned by their respective owners.
RSS | Privacy | Disclaimer | TOS | Feedback
EPR Network LLC disclaims any content found in press releases published on its network - full disclaimer. Powered by WP. Theme by MH Themes
In the works: Consolidated Press Release Distribution | Social Press Release | Early Bird Press Release